| http://www.w3.org/ns/prov#value | - of HCV are currently being developed.7 In this review we examine how the presently available agents have changed the management of patients with hepatitis C. In the past, treatment was limited to monotherapy with various types of interferon (i.e., interferon alpha-2a, interferon alpha-2b and consensus interferon) that have similar immunomodulatory and antiviral effects.
|
